Jecure Therapeutics

Biotechnology ResearchCalifornia, United States0-1 Employees

Jecure Therapeutics is a biotechnology research company pursuing the discovery of new therapeutics for non-alcoholic steatohepatitis (NASH) and liver fibrosis. Based in San Diego, California, it sits within the region's active biotech ecosystem. The firm traces its academic roots to Dr. Ariel Feldstein, a gastroenterology expert at UC San Diego School of Medicine, and it combines his laboratory-derived hepatology biology with a team of experienced discovery scientists. Its lead program centers on inhibitors that target a novel inflammatory driver implicated in NASH.

In the biotechnology research sector, the company concentrates on translating hepatology biology into early-stage drug discovery. With a very small team based in San Diego, it aims to develop therapeutic candidates that could be taken forward by pharmaceutical and biotech developers focused on liver disease.

Sign up for free to view info

Email Format Employee directory